Benutzer: Gast  Login
Titel:

Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects.

Dokumenttyp:
Journal Article; Review
Autor(en):
Weber, MS; Menge, T; Lehmann-Horn, K; Kronsbein, HC; Zettl, U; Sellner, J; Hemmer, B; Stüve, O
Abstract:
Recent years have broadened the spectrum of therapeutic strategies and specific agents for treatment of multiple sclerosis (MS). While immune-modulating drugs remain the first-line agents for MS predominantly due to their benign safety profile, our growing understanding of key processes in initiation and progression of MS has pioneered development of new agents with specific targets. One concept of these novel drugs is to hamper migration of immune cells towards the affected central nervous syst...     »
Zeitschriftentitel:
Curr Pharm Des
Jahr:
2012
Band / Volume:
18
Heft / Issue:
2
Seitenangaben Beitrag:
209-19
Sprache:
eng
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/22229582
Print-ISSN:
1381-6128
TUM Einrichtung:
Neurologische Klinik und Poliklinik
 BibTeX